Study ID: Ergomed AEZS-108-050 Advanced Endometrial Ca
Title:

Randomized controlled study comparing AEZS-108 with doxorubicin as second line therapy for locally advanced, recurrent or metastatic endometrial cancer

Location:
Fargo Region, Sioux Falls Region
Principal Investigator:
Maria Bell MD
Disease:
Endometrial
Stage:
Phase III

Status:

Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.

Back to Clinical Trials list